| Today's Big NewsNov 7, 2022 |
|
Talent matters more than ever. And Greater Philadelphia’s growth and development of this critical asset is one reason JLL ranked the region as its No. 5 Life Sciences cluster in the U.S. Learn how the region can fuel your company’s growth. Learn more. 
|
|
| By Angus Liu GSK’s dream just turned into a nightmare. The company's BCMA-targeted Blenrep has failed in a phase 3 multiple myeloma trial, putting its accelerated approval in jeopardy. |
|
|
|
By James Waldron It may have made its name—and fortune—with a COVID shot, but mRNA pioneer BioNTech is thinking bigger for 2023, with up to five trials for infectious disease vaccines set to enter the clinic. |
By Paige Minemyer We're honoring 10 women making a difference in pushing healthcare to the future. This year's list covers the breadth of the industry, from providers to payers to health tech, and represents some of the industry's largest companies as well as up-and-coming innovators. |
By Andrea Park These days, employer-sponsored wellness programs are a dime a dozen—but Verily may have hit the jackpot with its own Onduo virtual care platform. |
|
Wednesday, November 16, 2022 | 11am ET / 8am PT Process characterization is an important step in the product development journey. Join this webinar where experts share case studies in developing a stepwise approach for process validation. Register now. 
|
|
By Fraiser Kansteiner Monday, the U.S. Supreme Court declined to hear Bristol Myers Squibb's case to resurrect a $1.2 billion win in its five-year dispute over a Juno Therapeutics' CAR-T patent and Gilead’s cell therapy Yescarta. |
By Max Bayer Flagship-founded Repertoire Immune Medicines is completely reshuffling following news that it had laid off nearly half of its staff. The company disclosed Monday that it had culled its top two assets and was replacing its founding CEO. |
By Heather Landi VillageMD, which is majority owned by Walgreens Boots Alliance, plans to shell out nearly $9 billion to pick up medical practice Summit Health, the parent company of urgent care clinic chain CityMD. |
By Andrea Park After receiving a few dozen reports of issues with its respiratory filters, Teleflex has initiated a recall of more than 61,000 of the devices. |
By Zoey Becker After saying goodbye to biosimilars by divesting its copycat biologics franchise to Biocon Biologics, Viatris is saying hello to ophthalmology with the buyouts of Oyster Point Pharma and Fany Life Sciences. The two deals will add at least $1 billion in sales by 2028, the company said. |
By Gabrielle Masson With fleshed-out phase 2 data, Amgen says it will launch a phase 3 for its heart drug olpasiran by the end of this year. |
By Annalee Armstrong Verve Therapeutics’ lead gene editing candidate has lost some steam after running into an FDA clinical hold. |
By Dave Muoio The Children's Hospital Association penned a letter of lame duck requests that included hundreds of millions for pediatric workforce training, the passage of legislation improving kids' access to care and protections on healthcare coverage for children. |
By Conor Hale According to the UConn researchers, their implant never needs its batteries changed. They instead rely on the expansion and contraction of the chest each time the user takes a breath. |
Fierce podcasts Don't miss an episode |
| This week on “The Top Line,” we dig into Philips’ revelation that it is laying off 4,000 workers and planning for even more restructuring. |
|
|---|
|
|
|
Tuesday, November 15, 2022 | 1pm ET / 10am PT In this webinar, learn how Medable is focused on improving access to clinical trials for patients, supporting the innovation of clinical trial delivery and offering greater choices for participation and engagement to patients. Register now. 
|
|
Webinar Twist Bioscience CSO Dr. Aaron Sato shares how Twist's tools for antibody discovery have been applied to identify antibodies against diverse and challenging targets. See how high-throughput DNA synthesis combined with antibody engineering expertise provides end-to-end antibody discovery solutions. Presented by: Twist Bioscience |
Whitepaper This paper outlines how gene therapy supply chains are different from traditional biopharma products, as well as the factors that are essential to success. Sponsored by: Blue Matter |
Video Revolutionize your monoclonal antibody (mAb) manufacturing process with the Gibco™️ Efficient-Pro™️ Medium and Feed System. Watch our how-to video. Sponsored by: Thermo Fisher Scientific |
Whitepaper What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent |
Research Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent |
Whitepaper How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent |
Whitepaper Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Biologics |
Webinar Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics |
Whitepaper Clarus Therapeutics (Clarus) is a men’s specialty pharmaceutical company that partnered with Catalent to develop a unique and convenient drug delivery form for their hormone replacement therapy. Sponsored by: Catalent |
Whitepaper Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Catalent |
eBook Orally Inhaled & Nasal Drug Delivery: A Pipeline of Opportunities Sponsored By: Catalent |
Whitepaper Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored By: Catalent |
Whitepaper What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored By: Catalent |
| |
|
